Journal of Traditional Chinese Medicine >
Huangqi decoction (黄芪汤) attenuates renal interstitial fibrosis via transforming growth factor-β1/mitogen-activated protein kinase signaling pathways in 5/6 nephrectomy mice
Received date: 2021-07-12
Accepted date: 2021-10-14
Online published: 2022-09-02
Supported by
National Natural Science Fund(81903994);Youth Development of the First Affiliated Hospital of Anhui Medical University(2793);Budget Project of Shanghai University of Chinese Medicine(2019LK095)
OBJECTIVE: To investigate the effect of Huangqi decoction (黄芪汤) on renal interstitial fibrosis and its association with the transforming growth factor-β1 (TGF-β1) / mitogen-activated protein kinase (MAPK) signaling pathway.
METHODS: 120 C57/BL mice were randomly divided into six groups: sham group, Enalapril (20 mg/kg) group, 5/6 nephrectomy model group, and 5/6 nephrectomy model plus Huangqicoction (0.12, 0.36 and 1.08 g/kg respectively) groups. Detecting 24hours urinary protein, blood pressure, serum creatinine, urea nitrogen content changes. Periodic Acid-Schiff stain (PAS) and Masson's trichrome staining was used to observe the renal tissue pathological changes. Protein expression of TGF-β1, Phosphorylated P38 mitogen activated protein kinases (P-P38), Phosphorylated c-jun N-terminal kinase (P-JNK), Phosphorylated extracellular regulated proteinhnase (P-ERK), Fibroblast-specific protein-1 (FSP-1), Alpha smooth muscle actin (α-SMA), Type III collagen (Collagen III), Connective tissue growth factor (CTGF), Bcl-2 Assaciated X protein (Bax) and B cell lymphoma 2 (Bcl-2) were measured with western blot and immunohistochemical.
RESULTS: Both Huangqi decoction and Enalapril improved the kidney function, 24 h urinary protein and the fibrosis in 5/6 nephrectomy mice, Huangqi decoction downregulated the expressions of TGF-β1, FSP-1, α-SMA, Collagen III and CTGF in a dose-dependent manner, and it has a significant difference (P < 0.01) compared with model group.Huangqi decoction downregulated the expressions of P-P38, P-JNK, P-ERK and Bcl-2 in a dose-dependent manner, while upregulated the expression of Bax.
CONCLUSIONS: The protective effect of Huangqi decoction for renal interstitial fibrosis in 5/6 nep-hrectomized mice via the inhibition of Epithelial-Mesenchymal Transitions and downregulating the TGF-β1/ MAPK signaling pathway.
Jie ZHAO , Li WANG , Ai-li CAO , Yun-man WANG , Yang-feng CHI , Yi WANG , Hao WANG , Wen PENG . Huangqi decoction (黄芪汤) attenuates renal interstitial fibrosis via transforming growth factor-β1/mitogen-activated protein kinase signaling pathways in 5/6 nephrectomy mice[J]. Journal of Traditional Chinese Medicine, 2022 , 42(5) : 723 -731 . DOI: 10.19852/j.cnki.jtcm.2022.05.006
| 1. | Kawada T. Carotid intima-media thickness and cardiovascular risk in patients with diabetes mellitus type 2 and chronic kidney disease. Ren Fail 2020; 42: 330-3322. |
| 2. | Liang S, Wu YS, Li DY, et al. Autophagy and renal fibrosis. Aging Dis 2022; 13: 712-31. |
| 3. | Lee JW, An JN, Hwang JH, et al. p38 MAPK activity is associated with the histological degree of interstitial fibrosis in IgA nephropathy patients. PLoS One 2019; 14: p. e0213981. |
| 4. | Shu SS, Liu H, Yang JZ, et al. Targeted inhibition of ZAK ameliorates renal interstitial fibrosis. Transl Res 2022; 246: 49-65. |
| 5. | Zhang X, Lu H, Xie SS, et al. Resveratrol suppresses the myofibroblastic phenotype and fibrosis formation in kidneys via proliferation-related signalling pathways. Br J Pharmacol 2019; 176: 4745-59. |
| 6. | Hong WL, Zhang G, Lu H, et al. Epithelial and interstitial Notch 1 activity contributes to the myofibroblastic phenotype and fibrosis. Cell Commun Signal 2019; 12; 17: 145. |
| 7. | Zhao J, Wang L, Cao AL, et al. Huangqi decoction ameliorates renal fibrosis via tgf-beta/smad signaling pathway in vivo and in vitro. Cell Physiol Biochem 2016; 38: 1761-74. |
| 8. | Chu S, Mao XD, Wang L, et al. Effects of Huang Qi decoction on endothelial dysfunction induced by homocysteine. Evid Based Complement Alternat Med 2016; 2016: 7272694. |
| 9. | Zhou X, Sun X, Gong X, et al. Astragaloside IV from Astragalus membranaceus ameliorates renal interstitial fibrosis by inhibiting inflammation via TLR4/NF-small ka, CyrillicB in vivo and in vitro. Int Immunopharmacol 2017; 42: 18-24. |
| 10. | Che X, Wang Q, Xie Y, et al. Astragaloside IV suppresses transforming growth factor-beta1 induced fibrosis of cultured mouse renal fibroblasts via inhibition of the MAPK and NF-kappaB signaling pathways. Biochem Biophys Res Commun 2015; 464: 1260-6. |
| 11. | Li Z, Deng W, Cao A, et al. Huangqi decoction inhibits hyperglycemia-induced podocyte apoptosis by down-regulated Nox4/p53/Bax signaling in vitro and in vivo. Am J Transl Res 2019; 11: 3195-3212. |
| 12. | Wang M, Chen DQ, Wang MC, et al. Poricoic acid ZA, a novel RAS inhibitor attracted from Wolfiporia extensa, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway. Phytomedicine 2017; 36: 243-253. |
| 13. | Zhang Y, Zhang D, Zhang M. Inhibition mechanism of compound ethanol extracts from Wuweizi (Fructus Schisandrae Chinensis) on renal interstitial fibrosis in diabetic nephropathy model mice. J Tradit Chin Med 2012; 32: 669-73. |
| 14. | Chen ZJ, Ma F, Sun XM, et al. Renoprotective Effect of a Chinese herbal formula, Qidan Dihuang decoction, on streptozotocin-induced diabetes in rat. Evid Based Complement Alternat Med 2018; 2018: 7321086. |
| 15. | Liu D. and Lv LL. New understanding on the role of proteinuria in progression of chronic kidney disease. Adv Exp Med Biol 2019; 1165: 487-500. |
| 16. | Yang Z, He LJ, Sun SR. Role of endothelial cells in renal fibrosis. Adv Exp Med Biol 2019; 1165: 145-63. |
| 17. | Qiu ZZ, He JM, Zhang HX, et al. Renoprotective effects of pirfenidone on chronic renal allograft dysfunction by reducing renal interstitial fibrosis in a rat model. Life Sci 2019; 233: 116666. |
| 18. | de Frutos S, Luengo A, García-Jérez A, et al. Chronic kidney disease induced by an adenine rich diet upregulates integrin linked kinase (ILK) and its depletion prevents the disease progression. Biochim Biophys Acta Mol Basis Dis 2019; 1865: 1284-97. |
| 19. | Higashi AY, Aronow BJ, Dressler GR. Expression profiling of fibroblasts in chronic and acute disease models reveals novel pathways in kidney fibrosis. J Am Soc Nephrol 2019; 30: 80-94. |
| 20. | Liu BC, Tang TT, Lv LL, et al. Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int 2018; 93: 568-79. |
| 21. | Liu M, Ning X, Li R, et al. Signalling pathways involved in hypoxia-induced renal fibrosis. J Cell Mol Med 2017; 21: 1248-59. |
| 22. | Li ZL, Liu BC. Hypoxia and renal tubulointerstitial fibrosis. Adv Exp Med Biol 2019; 1165: 467-85. |
| 23. | Vanhove T, Goldschmeding R, Kuypers D. Kidney fibrosis: origins and interventions. Transplantation 2017; 101: 713-26. |
| 24. | Suárez-Álvarez B, Liapis H, Anders HJ. Links between coagulation, inflammation, regeneration, and fibrosis in kidney pathology. Lab Invest 2016; 96: 378-90. |
| 25. | Su H, Wan C, Song A, et al. Oxidative stress and renal fibrosis: mechanisms and therapies. Adv Exp Med Biol 2019; 1165: 585-604. |
| 26. | Chen Y, Lin L, Tao X, et al. The role of podocyte damage in the etiology of ischemia-reperfusion acute kidney injury and post-injury fibrosis. BMC Nephrol 2019; 20: 106. |
| 27. | Chung S, Kim S, Son M, et al. Inhibition of p300/CBP-associated factor attenuates renal tubulointerstitial fibrosis through modulation of NF-kB and Nrf2. Int J Mol Sci 2019; 20: 1554. |
| 28. | Yin Q, Liu H. Connective tissue growth factor and renal fibrosis. Adv Exp Med Biol 2019; 1165: 365-80. |
| 29. | Gewin LS. Renal fibrosis: primacy of the proximal tubule. Matrix Biol 2018; 68-69: 248-62. |
| 30. | Cruz-Solbes AS, Youker K. Epithelial to mesenchymal transition (EMT) and endothelial to mesenchymal transition (EndMT): role and implications in kidney fibrosis. Results Probl Cell Differ 2017; 60: 345-72. |
| 31. | Annaldas S, Saifi MA, Khurana A, et al. Nimbolide ameliorates unilateral ureteral obstruction-induced renal fibrosis by inhibition of TGF-beta and EMT/Slug signalling. Mol Immunol 2019; 112: 247-55. |
| 32. | Wang S, Zhou Y, Zhang Y, et al. Roscovitine attenuates renal interstitial fibrosis in diabetic mice through the TGF-beta1/p 38 MAPK pathway. Biomed Pharmacother 2019; 115: 108895. |
| 33. | Sugiyama N, Kohno M, Yokoyama T. Inhibition of the p38 MAPK pathway ameliorates renal fibrosis in an NPHP2 mouse model. Nephrol Dial Transplant 2012; 27: 1351-8.. |
| 34. | Ghasemian M, Rajabibazl M, Sahebi U, et al. Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders. Cancer Cell Int 2022; 22: 215. |
| 35. | Zeng X, Cai G, Liang T, et al. Rhubarb and Astragalus capsule attenuates renal interstitial fibrosis in rats with unilateral ureteral obstruction by alleviating apoptosis through regulating transforming growth factor beta1 (TGF-β1)/p38 mitogen-activated protein kinases (p38 MAPK) pathway. Med Sci Monit 2020; 26: e920720-1-14. |
| 36. | Lindqvist LM, Heinlein M, Huang DC, et al. Prosurvival Bcl-2 family members affect autophagy only indirectly, by inhibiting Bax and Bak. Proc Natl Acad Sci USA 2014; 111: 8512-17. |
/
| 〈 |
|
〉 |